NUA SURGICAL

Executive Summary

NUA Surgical is an Irish medical device startup dedicated to improving outcomes in women's health, particularly in obstetrics and gynecology. Founded in 2015 and based in Galway, the company is developing the SteriCISION C-Section Retractor, a novel device designed to address unmet clinical needs during caesarean deliveries. The retractor aims to enhance surgical safety, reduce complications, and improve recovery for mothers and babies. Despite being in the pre-clinical stage, NUA Surgical has garnered awards and recognition for its innovative approach to a common surgical procedure. The global caesarean section market presents a significant opportunity, with millions of procedures performed annually, yet limited innovation in surgical tools. NUA Surgical's focus on a clear clinical need positions it well for potential adoption, though the company faces the typical challenges of early-stage medical device development, including regulatory hurdles, clinical validation, and commercialization.

Upcoming Catalysts (preview)

• Q2 2027First-in-human clinical study initiation60% success
• Q4 2027FDA or CE mark submission for SteriCISION50% success
• Q3 2026Strategic partnership with a larger medical device company40% success